Ingredion Incorporated (NYSE:INGR) Shares Sold by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC reduced its stake in shares of Ingredion Incorporated (NYSE:INGR - Free Report) by 8.5% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 324,265 shares of the company's stock after selling 30,093 shares during the quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC owned approximately 0.50% of Ingredion worth $44,564,000 as of its most recent SEC filing.

Other institutional investors also recently added to or reduced their stakes in the company. Thurston Springer Miller Herd & Titak Inc. purchased a new position in Ingredion in the second quarter worth $26,000. EverSource Wealth Advisors LLC grew its stake in Ingredion by 102.6% during the 1st quarter. EverSource Wealth Advisors LLC now owns 233 shares of the company's stock worth $27,000 after buying an additional 118 shares during the last quarter. Point72 Asia Singapore Pte. Ltd. acquired a new position in Ingredion during the 2nd quarter valued at about $33,000. Prospera Private Wealth LLC acquired a new position in Ingredion during the 3rd quarter valued at about $41,000. Finally, Family Firm Inc. purchased a new stake in Ingredion in the second quarter valued at about $36,000. Institutional investors own 85.27% of the company's stock.

Ingredion Stock Performance

Shares of NYSE INGR traded down $0.32 during trading on Wednesday, reaching $148.79. 223,516 shares of the company traded hands, compared to its average volume of 387,098. Ingredion Incorporated has a 12-month low of $104.68 and a 12-month high of $155.44. The company has a current ratio of 2.67, a quick ratio of 1.69 and a debt-to-equity ratio of 0.44. The stock has a market cap of $9.69 billion, a P/E ratio of 14.48, a PEG ratio of 1.27 and a beta of 0.74. The firm's fifty day simple moving average is $140.11 and its 200 day simple moving average is $129.05.

Ingredion (NYSE:INGR - Get Free Report) last announced its quarterly earnings results on Tuesday, November 5th. The company reported $3.05 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $2.58 by $0.47. The company had revenue of $1.87 billion during the quarter, compared to the consensus estimate of $1.94 billion. Ingredion had a return on equity of 17.75% and a net margin of 9.05%. Ingredion's revenue for the quarter was down 8.0% on a year-over-year basis. During the same period in the previous year, the company posted $2.33 earnings per share. As a group, research analysts anticipate that Ingredion Incorporated will post 10.6 earnings per share for the current fiscal year.

Insider Buying and Selling

In other news, CFO James D. Gray sold 54,869 shares of the stock in a transaction that occurred on Friday, November 29th. The stock was sold at an average price of $146.76, for a total transaction of $8,052,574.44. Following the transaction, the chief financial officer now owns 12,795 shares in the company, valued at $1,877,794.20. This trade represents a 81.09 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, SVP Larry Fernandes sold 6,122 shares of the business's stock in a transaction on Friday, November 15th. The stock was sold at an average price of $140.66, for a total transaction of $861,120.52. Following the completion of the sale, the senior vice president now directly owns 29,034 shares of the company's stock, valued at approximately $4,083,922.44. The trade was a 17.41 % decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders have sold 66,197 shares of company stock valued at $9,702,315. Corporate insiders own 1.80% of the company's stock.

Analyst Upgrades and Downgrades

A number of brokerages have recently weighed in on INGR. Oppenheimer upped their price objective on shares of Ingredion from $147.00 to $178.00 and gave the company an "outperform" rating in a report on Wednesday, November 6th. BMO Capital Markets boosted their target price on shares of Ingredion from $128.00 to $147.00 and gave the stock a "market perform" rating in a research report on Wednesday, November 6th. Barclays raised their price target on shares of Ingredion from $145.00 to $168.00 and gave the stock an "overweight" rating in a report on Wednesday, November 6th. StockNews.com lowered shares of Ingredion from a "strong-buy" rating to a "buy" rating in a report on Wednesday, August 7th. Finally, UBS Group raised their target price on Ingredion from $165.00 to $173.00 and gave the stock a "buy" rating in a research note on Friday, November 15th. One equities research analyst has rated the stock with a hold rating and six have given a buy rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and a consensus target price of $155.17.

About Ingredion

Ingredion Incorporated, together with its subsidiaries, manufactures and sells sweeteners, starches, nutrition ingredients, and biomaterial solutions derived from wet milling and processing corn, and other starch-based materials to a range of industries in North America, South America, the Asia Pacific, Europe, the Middle East, and Africa.